Verified metrics from the field
Every number here is drawn from Mike's verified professional history. These aren't projections or industry benchmarks — they're the results he produced.
Building a National Vascular Division from Zero
Argon Medical Devices — Vascular Division
Argon recruited Mike as the first dedicated commercial leader for a newly formed Vascular division. There was $6.37M in existing division revenue but no sales team, no territory design, no commercial playbook, and no physician relationships. Mike was handed a blank slate.
- Territory architecture for a national commercial footprint
- Recruiting pipeline and hiring criteria for the division
- Onboarding curriculum and clinical training programs
- Performance management systems and commercial KPI framework
- KOL recruitment and activation for IDE-stage clinical trial
- National Sales Council (chaired by Mike)
Launching a VTE Territory from $200K to $6M
Inari Medical (acquired by Stryker for $4.9B, February 2025)
Mike joined Inari Medical as the founding commercial presence for Ohio and Kentucky — at the time, the territory had $200K in annual revenue and zero established physician relationships. He launched and scaled the territory during Inari's rapid national expansion, eventually serving as Field Sales Trainer for new hires across the country.
- Ohio/Kentucky VTE commercial presence from zero
- Regional KOL education program driving physician adoption
- Hospital VTE program development across multiple health systems
- Supported 700+ VTE procedures across the region
- Partnered with hospital billing teams on reimbursement and revenue capture
- Trained and onboarded new Field Sales hires nationally
IDE Trial Physician Activation — Magenta Medical
Magenta Medical is a clinical-stage company developing the Elevate percutaneous left ventricular assist device — currently in a pivotal randomized controlled trial against J&J Impella for high-risk PCI. The company has raised $183M, including a $105M round led by Novo Holdings. Bill Hoffman, former CEO of Inari Medical, serves on the board.
Mike established a direct relationship with Magenta CEO David Israeli and contributed to the company's IDE trial physician recruitment — connecting key interventional cardiologists to the Elevate pVAD program and supporting physician site activation for the pivotal trial.
Want results like these for your company?
Book a 30-minute discovery call to talk through where you are and where you need to go.
Book a Discovery Call